Photos: Peptides Discovered to Alleviate Chemotherapy Si...(ncreases the antioxidant levels inblood ...),Health

Date:11/20/2008

ncreases the antioxidant levels in blood by over 200 percent in a seven-day period, while nutrient-based antioxidants only increase levels marginally." Mr. Mollstedt continued, "Antioxidants act as a shield for healthy cells, while allowing chemotherapy to battle cancerous cells. AminoAct(TM) greatly increases the size of that shield."

Because chemotherapy attacks not only cancer cells, but all cells, oftentimes cancer patients must stop treatment due to chemotherapy side effects. However, like antibiotics, chemotherapy is most effective when given in complete cycles. "By dramatically increasing antioxidant levels, AminoAct(TM) helps patients to stay on their chemotherapy regimens, thus increasing the overall treatment impact," stated Dr. Tsai.

In addition to stimulating SOD production, AminoAct(TM) also increases the secretion of ghrelin, a stomach hormone that stimulates appetite. According to the American Cancer Society, weight loss in the main cause of death for 1 in 5 cancer patients. "Our research was focused on eradicating cancer by allowing chemotherapy to do the job it's intended to do," Dr. Tsai said. "Knowing that cancer patients often succumb to death due to weight loss, when we uncovered that AminoAct(TM) also increases ghrelin production, we were elated."

The milk-based peptides in AminoAct(TM) are unlocked through a proprietary technology, and do not have adverse effects on those who are lactose intolerant. For more information, visit www.onconutrition.com, or call 951- 231-2388.

    Media Contacts:
    Chris French
    714-710-9229; 714-225-6142-C
    cfrench@eqwestgroup.com

    Helen Chen
    951-231-2106
    helenc@onconutrition.com

'/>"/>

SOURCE OncoNutrition Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2
Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
3. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
4. Are Muramyl Peptides the Magic Bullet in Probiotics?
5. Tainted Chinese Food Ingredients First Discovered in 2005
6. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy